Calanolide A: Sarawak will begin in 3Q02 a U.S. Phase I trial of Calanolide A in 48 volunteers. Sarawak is a 50-50 joint venture between the state government of

Sarawak MediChem Pharmaceuticals Inc., Lemont, Ill. Product: Calanolide A Business: Infectious diseases Therapeutic category: Viral replication Target: Reverse transcriptase Description: Naturally occ...